Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prion protein mRNA (encoded by the PRNP gene in humans and Prnp in mice) is the messenger RNA template responsible for the translation of cellular prion protein (PrPC). In prion diseases—such as Creutzfeldt-Jakob disease (CJD), fatal familial insomnia (FFI), and Gerstmann-Straussler-Scheinker (GSS) syndrome—the normal PrPC protein undergoes a conformational transition into a pathogenic, misfolded, and infectious form known as PrPSc. Because PrPC is the essential substrate required for prion replication and propagation, reducing its expression is a highly validated therapeutic strategy. Therapeutic modalities targeting PRNP mRNA include antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs). These drugs, such as ION717 and ALN-6457, bind to PRNP mRNA to trigger its degradation via RNase H1 or the RNA-induced silencing complex (RISC), respectively, thereby lowering PrPC levels in the brain and halting the progression of neurodegeneration.
Antisense oligonucleotides (such as ION717) bind to the complementary PRNP mRNA sequence and trigger RNase H1-mediated degradation of the transcript. Small interfering RNAs (such as ALN-6457 and PrP-siRNA) utilize the RNA-induced silencing complex (RISC) to cleave the PRNP mRNA. Both mechanisms result in the knockdown of PRNP mRNA, thereby reducing the translation and expression of cellular prion protein (PrPC) and preventing its conversion into the pathogenic, misfolded prion protein (PrPSc).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prion protein mRNA (PRNP mRNA).